SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001607062-21-000250
Filing Date
2021-08-04
Accepted
2021-08-04 11:26:14
Documents
55
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-K rgbp093020form10k.htm 10-K 1967361
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 9500
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 9479
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 4226
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 4097
  Complete submission text file 0001607062-21-000250.txt   5564912

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE rgbp-20200930.xml EX-101.INS 812891
7 XBRL SCHEMA FILE rgbp-20200930.xsd EX-101.SCH 72088
8 XBRL CALCULATION FILE rgbp-20200930_cal.xml EX-101.CAL 49491
9 XBRL DEFINITION FILE rgbp-20200930_def.xml EX-101.DEF 195110
10 XBRL LABEL FILE rgbp-20200930_lab.xml EX-101.LAB 347794
11 XBRL PRESENTATION FILE rgbp-20200930_pre.xml EX-101.PRE 262759
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-722-5505
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 333-191725 | Film No.: 211142906
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences